UK Markets closed

Head and Neck Cancer Diagnostic Market Market Research Report 2023: Elevating Need for Effective Targeted Treatment Boosts Market Growth - Trends, Opportunities and Forecasts to 2027

Company Logo
Company Logo

Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics), By Diagnostic Imaging, By Endoscopy, By Dental Diagnostics, By End User, and By Region" report has been added to's offering.

The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027

The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.

Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth.

Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth.

The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.

Increasing Incidences of Cancer Propels the Market Growth

The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market.

As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.

Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth

Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ.

Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are a few of the common diagnostic procedures which are performed upon the patients.

Elevating Need for Effective Targeted Treatment Boosts the Market Growth

Treatment for head and neck cancer is a challenging task for many oncologists.

Treatment availability and choice depend upon the location of cancer and vary from patient to patient. Due to the facial structure's complexity, the surgical treatments for head and neck cancers become complex, with surgery being the preferred mode of treatment mode among healthcare professionals.

Onco-surgeon prefers surgical therapy in combination with radiation therapy for head and neck cancer treatment. For better results after surgery, accurate diagnosis plays a significant role in analyzing the cancer severity. The introduction of targeted molecular therapy, including gene therapy, antibody-drug conjugates, and monoclonal antibodies, offers a potential avenue for the global head and neck cancer diagnostics market.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer diagnostics market.

  • Addent Inc

  • GE Healthcare

  • Koninklijke Philips NV

  • Shimadzu Corporation

  • Siemens Healthineers AG

  • Fujifilm Holdings Corporation

  • Canon Medical system Corporation

  • Carestream Healthcare Inc.

  • Neusoft Medical Systems Co., Ltd.

  • Varian Medical Systems, Inc.

Report Scope:

Head and Neck Cancer Diagnostics Market, By Type:

  • Diagnostic Imaging

  • PET/CT

  • MRI

  • X-Ray

  • Others

  • Biopsy

  • Incisional Biopsy

  • Fine Needle Aspiration Biopsy

  • HPV Testing

  • Endoscopy

  • Pharyngoscopy

  • Laryngoscopy

  • Panendoscopy

  • Dental Diagnostics

  • Brush Biopsy

  • Fluorescence Visualization

  • Acetic Acid Rinse Method

  • Toluidine Blue Dye-Based Method

Head and Neck Cancer Diagnostics Market, By End-User:

  • Hospitals

  • Specialty Clinics

  • Ambulatory Surgical Centers

  • Others

Head and Neck Cancer Diagnostics Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East & Africa

  • Saudi Arabia

  • South Africa

  • UAE

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900